The current study exhibited an effective decrease of p-JAK2 and p-STAT3 protein levels upon oridonin treatment in thyroid cancer TPC-1 and BCPAP cells, as evidenced by western blotting. The gene discussed is STAT3; the disease is thyroid gland carcinoma.